发明名称 NOVEL PHENYLALANINE DERIVATIVES
摘要 Phenylalanine derivatives represented by general formula (1) or pharmaceutically acceptable salts thereof: wherein x represents an interatomic bond, -O-, etc.; Y and Z represent each -C(=O)-, etc.; A represents a specific substituted phenyl group, a specific nitrogen-containing heterocycle, etc.; C represents hydrogen, alkly, etc.; D and E represent each alkyl or D and E may be bonded to each other to form a ring, etc.; F and G represent each hydrogen or alkyl, or F and G may be bonded to each otherto form a ring, etc.; n is from 0 to 2; K represents OR7, NR7R8, R7, etc.; and J and J' represent each hydrogen, halogeno, etc. These derivatives and analogs thereof show an alpha 4 integlin inhibitory activity and are usable as remedies for various diseases relating to alpha 4 integlin.
申请公布号 WO0136376(A1) 申请公布日期 2001.05.25
申请号 WO2000JP08152 申请日期 2000.11.20
申请人 AJINOMOTO CO., INC.;TANAKA, YASUHIRO;YOSHIMURA, TOSHIHIKO;IZAWA, HIROYUKI;EJIMA, CHIEKO;KOJIMA, MITSUHIKO;SATAKE, YUKO;NAKANISHI, EIJI;SUZUKI, NOBUYASU;MAKINO, SHINGO;SUZUKI, MANABU;MURATA, MASAHIRO 发明人 TANAKA, YASUHIRO;YOSHIMURA, TOSHIHIKO;IZAWA, HIROYUKI;EJIMA, CHIEKO;KOJIMA, MITSUHIKO;SATAKE, YUKO;NAKANISHI, EIJI;SUZUKI, NOBUYASU;MAKINO, SHINGO;SUZUKI, MANABU;MURATA, MASAHIRO
分类号 A61P1/04;A61P3/10;A61P9/00;A61P9/10;A61P11/06;A61P17/06;A61P19/02;A61P29/00;A61P35/00;A61P35/04;A61P37/06;A61P37/08;A61P43/00;C07C235/74;C07C275/42;C07C311/08;C07C311/10;C07C311/13;C07C311/16;C07C311/21;C07C311/29;C07C311/44;C07C317/44;C07C323/25;C07C323/60;C07C323/62;C07C335/22;C07D207/12;C07D207/14;C07D207/16;C07D239/38;C07D239/42;C07D295/185;(IPC1-7):C07C233/47;C07C233/63;C07C233/81;C07D295/18;C07D211/62;C07D211/42;C07D211/46;C07D207/08;C07D487/08;C07D207/09;C07D265/30;C07D309/08;C07D211/22;C07D223/06;C07D207/20;C07D491/08;C07D495/08;C07D217/06;C07D471/08;C07D405/06;C07D285/06;A61K31/198;A61K31/40;A61K31/495;A61K31/537;A61K31/54;A61K31/445;A61K31/55;A61K31/407;A61K31/402;A61K31/001;A61K31/472;A61K31/437;A61K31/351;A61K31/403 主分类号 A61P1/04
代理机构 代理人
主权项
地址